Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
04/10/2002 | EP1195161A2 Anti-IgE vaccines |
04/10/2002 | EP1194563A1 Fimh adhesin-based vaccines |
04/10/2002 | EP1194561A2 Donor strand complemented pilin and adhesin broad-based vaccines |
04/10/2002 | EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
04/10/2002 | EP1194439A1 Human eag2 |
04/10/2002 | EP1194429A1 Potassium channel openers |
04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
04/10/2002 | EP0927150B1 Lipoxin compounds and their use in treating cell proliferative disorders |
04/10/2002 | EP0819009B1 Ovulation triggering drugs comprising luteinising hormone |
04/10/2002 | EP0732329B1 Chroman derivative |
04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
04/10/2002 | CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors |
04/10/2002 | CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
04/10/2002 | CN1344161A Use of pyridazino [4,5-i(b)]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
04/10/2002 | CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues |
04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
04/10/2002 | CN1343518A Efficacy and application of soft capsule or oily pill prepared by mixing tomato seed oil with rubin |
04/10/2002 | CN1343504A Composite medicine for treating nephrosis and its preparing process |
04/09/2002 | US6369222 mGluR antagonists and a method for their synthesis |
04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
04/09/2002 | US6369084 Prostaglandin mediated diseases |
04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
04/09/2002 | US6369059 Tetracyclic derivatives, process of preparation and use |
04/09/2002 | US6369056 Agonists and antagonists of the progesterone receptor; contraceptives; 6-(3-chlorophenyl)-4,4-dimethyl-1,4-dihydro -3-oxa-1,8-diaza-naphthalene-2-one and 6-chloro-4,4-dimethyl-1,4-dihydro-3-oxa-1,5-diaza-naphthalen-2-one |
04/09/2002 | CA2298572C Deuterated cyclosporine analogs and their use as immunomodulating agents |
04/09/2002 | CA2090321C Therapeutically useful 2-aminotetralin derivatives |
04/04/2002 | WO2002026781A2 Ige receptor antagonists |
04/04/2002 | WO2002026733A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
04/04/2002 | WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy |
04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
04/04/2002 | WO2002026704A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
04/04/2002 | WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same |
04/04/2002 | WO2002026245A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions |
04/04/2002 | WO2002026223A2 Catecholamine pharmaceutical compositions and methods |
04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
04/04/2002 | WO2002014281A8 Pyridine derivatives as inhibitors of p38 |
04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
04/04/2002 | WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors |
04/04/2002 | WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists |
04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
04/04/2002 | WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta |
04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
04/04/2002 | WO2001044197A3 2-phenyl-quinoline derivatives and their use as contracting agent for smooth muscles |
04/04/2002 | US20020040150 Skin treatment compositons containing a cationic polymer and a microparticle or nanoparticle vector |
04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
04/04/2002 | US20020040059 Controlling cancer by reducing its growth and improving response to therapy |
04/04/2002 | US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
04/04/2002 | US20020040028 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia |
04/04/2002 | US20020040016 Derivatives of azetidine and pyrrolidine |
04/04/2002 | US20020040007 Novel macrolide antibiotics |
04/04/2002 | US20020039996 Pharmaceutical administration form for peptides, process for its preparation, and use |
04/04/2002 | US20020039736 Reacting aliphatic aminonitrile with water in presence of solid alumina catalyst to form lactam |
04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
04/04/2002 | DE10043846A1 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen 17-methyl steroids, processes for their preparation and pharmaceutical compositions containing this compound |
04/04/2002 | CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation |
04/04/2002 | CA2424021A1 Catecholamine compositions and uses thereof |
04/04/2002 | CA2423474A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
04/04/2002 | CA2423313A1 Methods of treating inflammatory and immune reactions and compositions therefor |
04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
04/04/2002 | CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
04/04/2002 | CA2421209A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
04/04/2002 | CA2420475A1 Ige receptor antagonists |
04/03/2002 | EP1193268A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
04/03/2002 | EP1192949A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
04/03/2002 | EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase |
04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
04/03/2002 | EP1192163A1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
04/03/2002 | EP1192161A2 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands |
04/03/2002 | EP1191944A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
04/03/2002 | EP1191943A1 Novel anti-allergic agents |
04/03/2002 | EP1191941A1 A method for the prophylaxis and/or treatment of medical disorders |
04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
04/03/2002 | EP1191939A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
04/03/2002 | CN1343201A Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
04/03/2002 | CN1343174A 计量阀 Metering valve |
04/03/2002 | CN1342480A Guben pill and its preparing process |
04/03/2002 | CN1342458A Application of leflunomide in preparing medicines to treat lupoid nephritis and nephrotic syndrome |
04/03/2002 | CN1342457A Method for preventing vomit and sexual disorder using tetrahydrobenzo [cd] indole-6-formylamine compound |
04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
04/02/2002 | US6365736 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
04/02/2002 | US6365609 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
04/02/2002 | US6365599 For therapy of benign prostatic hyperplasia |